More on IAM

- Summary
- Chart
- Profile
- Historical

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Iambic Therapeutics (NQ:IAM)
Delayed: 14.78 +0.78 (5.57%)
Prev. Close $14.00  
Open$13.84 
52 Wk High$ 
52 Wk Low$ 
Day High$16.50 
Day Low$13.60 
P/E N/A  
EPS$ 
Volume926,210 


Oct 26, 2026 08:01 AM Iambic shares IAM1363 trial data at ESMO showing HER2 responses
Oct 26, 2026 08:00 AM Iambic Presents Updated IAM1363 Clinical Data at ESMO 2026, Showing Durable Responses with a Favorable Tolerability Profile in Heavily Pretreated Participants with HER2-Driven Cancers
Oct 19, 2026 08:20 PM Form 4 Iambic Therapeutics, For: Oct 16 Filed by: Petrocheilos George C
Oct 19, 2026 07:53 PM Form 4 Iambic Therapeutics, For: Oct 16 Filed by: Vogelstein R Jacob
Oct 19, 2026 07:51 PM Form 4 Iambic Therapeutics, For: Oct 16 Filed by: Secora Michael
Oct 19, 2026 07:49 PM Form 4 Iambic Therapeutics, For: Oct 16 Filed by: RASTETTER WILLIAM H
Oct 19, 2026 07:47 PM Form 4 Iambic Therapeutics, For: Oct 16 Filed by: Rachlin Evan Lockwood
Oct 16, 2026 05:04 PM Form 8-K Iambic Therapeutics, For: Oct 16
Oct 16, 2026 04:28 PM Form 4 Iambic Therapeutics, For: Oct 14 Filed by: EMSTER KURT VON
Oct 16, 2026 04:26 PM Form 4 Iambic Therapeutics, For: Oct 14 Filed by: Vogelstein R Jacob
View All Articles

Entities mentioned with IAM

View All Entities